195 related articles for article (PubMed ID: 23698203)
1. Chronic urticaria with high IgE levels: first results on oral cyclosporine A treatment.
Guaragna MA; Albanesi M; Stefani S; Franconi G; Di Stanislao C; Paparo Barbaro S
Clin Ter; 2013; 164(2):115-8. PubMed ID: 23698203
[TBL] [Abstract][Full Text] [Related]
2. Comparison of short- and long-term cyclosporine A therapy in chronic idiopathic urticaria.
Baskan EB; Tunali S; Turker T; Saricaoglu H
J Dermatolog Treat; 2004 Jun; 15(3):164-8. PubMed ID: 15204149
[TBL] [Abstract][Full Text] [Related]
3. Treatment of chronic autoimmune urticaria with omalizumab.
Kaplan AP; Joseph K; Maykut RJ; Geba GP; Zeldin RK
J Allergy Clin Immunol; 2008 Sep; 122(3):569-73. PubMed ID: 18774392
[TBL] [Abstract][Full Text] [Related]
4. Treatment of autoimmune urticaria with low-dose cyclosporin A: A one-year follow-up.
Boubouka CD; Charissi C; Kouimintzis D; Kalogeromitros D; Stavropoulos PG; Katsarou A
Acta Derm Venereol; 2011 Jan; 91(1):50-4. PubMed ID: 21264453
[TBL] [Abstract][Full Text] [Related]
5. Factors that predict the success of cyclosporine treatment for chronic urticaria.
Hollander SM; Joo SS; Wedner HJ
Ann Allergy Asthma Immunol; 2011 Dec; 107(6):523-8. PubMed ID: 22123382
[TBL] [Abstract][Full Text] [Related]
6. IgE levels are negatively correlated with clinical response to ciclosporin in chronic spontaneous urticaria.
Santiago L; Ferreira B; Ramos L; Gonçalo M
Br J Dermatol; 2019 Jan; 180(1):199-200. PubMed ID: 30007073
[No Abstract] [Full Text] [Related]
7. Activated status of basophils in chronic urticaria leads to interleukin-3 hyper-responsiveness and enhancement of histamine release induced by anti-IgE stimulus.
Lourenço FD; Azor MH; Santos JC; Prearo E; Maruta CW; Rivitti EA; Duarte AJ; Sato MN
Br J Dermatol; 2008 May; 158(5):979-86. PubMed ID: 18341658
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of omalizumab in patients with chronic urticaria who exhibit IgE against thyroperoxidase.
Maurer M; Altrichter S; Bieber T; Biedermann T; Bräutigam M; Seyfried S; Brehler R; Grabbe J; Hunzelmann N; Jakob T; Jung A; Kleine-Tebbe J; Mempel M; Meurer M; Reich K; Ruëff F; Schäkel K; Sengupta K; Sieder C; Simon JC; Wedi B; Zuberbier T; Mahler V; Staubach P
J Allergy Clin Immunol; 2011 Jul; 128(1):202-209.e5. PubMed ID: 21636116
[TBL] [Abstract][Full Text] [Related]
9. A retrospective review of clinical presentation, thyroid autoimmunity, laboratory characteristics, and therapies used in patients with chronic idiopathic urticaria.
Najib U; Bajwa ZH; Ostro MG; Sheikh J
Ann Allergy Asthma Immunol; 2009 Dec; 103(6):496-501. PubMed ID: 20084843
[TBL] [Abstract][Full Text] [Related]
10. Low-dose and short-term cyclosporine treatment in patients with chronic idiopathic urticaria: a clinical and immunological evaluation.
Serhat Inaloz H; Ozturk S; Akcali C; Kirtak N; Tarakcioglu M
J Dermatol; 2008 May; 35(5):276-82. PubMed ID: 18477227
[TBL] [Abstract][Full Text] [Related]
11. Response to oral cyclosporine therapy and high sensitivity-CRP level in chronic idiopathic urticaria.
Ohtsuka T
Int J Dermatol; 2010 May; 49(5):579-84. PubMed ID: 20534097
[TBL] [Abstract][Full Text] [Related]
12. Autoantibodies against the high-affinity IgE receptor as a cause of histamine release in chronic urticaria.
Hide M; Francis DM; Grattan CE; Hakimi J; Kochan JP; Greaves MW
N Engl J Med; 1993 Jun; 328(22):1599-604. PubMed ID: 7683772
[TBL] [Abstract][Full Text] [Related]
13. Six cases of antihistamine-resistant dermographic urticaria treated with oral ciclosporin.
Toda S; Takahagi S; Mihara S; Hide M
Allergol Int; 2011 Dec; 60(4):547-50. PubMed ID: 21778816
[TBL] [Abstract][Full Text] [Related]
14. Defective histamine release in chronic urticaria.
Kern F; Lichtenstein LM
J Clin Invest; 1976 May; 57(5):1369-77. PubMed ID: 57121
[TBL] [Abstract][Full Text] [Related]
15. Chronic autoimmune urticaria.
Wardhana ; Datau EA
Acta Med Indones; 2012 Apr; 44(2):165-74. PubMed ID: 22745150
[TBL] [Abstract][Full Text] [Related]
16. Effects of calcineurin inhibitors on an in vitro assay for chronic urticaria.
Marsland AM; Soundararajan S; Joseph K; Kaplan AP
Clin Exp Allergy; 2005 May; 35(5):554-9. PubMed ID: 15898974
[TBL] [Abstract][Full Text] [Related]
17. Pathogenesis of chronic urticaria.
Kaplan AP; Greaves M
Clin Exp Allergy; 2009 Jun; 39(6):777-87. PubMed ID: 19400905
[TBL] [Abstract][Full Text] [Related]
18. Chronic urticaria: pathogenesis and treatment.
Kaplan AP
J Allergy Clin Immunol; 2004 Sep; 114(3):465-74; quiz 475. PubMed ID: 15356542
[TBL] [Abstract][Full Text] [Related]
19. Experience with cyclosporine in children with chronic idiopathic urticaria.
Doshi DR; Weinberger MM
Pediatr Dermatol; 2009; 26(4):409-13. PubMed ID: 19689515
[TBL] [Abstract][Full Text] [Related]
20. Real-life experiences with omalizumab for the treatment of chronic urticaria.
Sussman G; Hébert J; Barron C; Bian J; Caron-Guay RM; Laflamme S; Stern S
Ann Allergy Asthma Immunol; 2014 Feb; 112(2):170-4. PubMed ID: 24468258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
